- Filed
- Feb 28, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2023 · Feb 24, 2024 | 5.58M sh |
| Sga Expense | FY 2023 · Nov 30, 2023 | $3.01M |
| Sga Expense | FY 2023 · Nov 30, 2022 | $3.31M |
| Shares Diluted | FY 2023 · Nov 30, 2022 | 5.73M sh |
| Capex | FY 2023 · Nov 30, 2022 | $48.35K |
| Operating Cash Flow | FY 2023 · Nov 30, 2022 | $2.24M |
| Cash And Equivalents | FY 2023 · Nov 30, 2022 | $8.69M |
| Current Liabilities | FY 2023 · Nov 30, 2022 | $5.95M |
| Total Liabilities | FY 2023 · Nov 30, 2022 | $7.12M |
| Current Assets | FY 2023 · Nov 30, 2022 | $22.8M |
| Total Assets | FY 2023 · Nov 30, 2022 | $24.62M |
| Eps Diluted | FY 2023 · Nov 30, 2022 | $0.65 |
| Eps Basic | FY 2023 · Nov 30, 2022 | $0.67 |
| Net Income | FY 2023 · Nov 30, 2022 | $3.74M |
| Operating Income | FY 2023 · Nov 30, 2022 | $4.72M |
| Gross Profit | FY 2023 · Nov 30, 2022 | $14.32M |
| Cost Of Revenue restated | FY 2023 · Nov 30, 2022 | $2.18K |
| Cost Of Revenue restated | FY 2023 · Nov 30, 2021 | $4.21K |
| Revenue | FY 2023 · Nov 30, 2022 | $51.91M |
| Stockholders Equity | FY 2023 · Nov 30, 2021 | $13.18M |